Youth with severe mental illness and complex non-somatic motor abnormalities: conflicting conceptualizations and unequal treatment.
Diagnosis
Paediatric research
Psychiatric disorders
Schizophrenia
Journal
Npj mental health research
ISSN: 2731-4251
Titre abrégé: Npj Ment Health Res
Pays: England
ID NLM: 9918592488906676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
02
2022
accepted:
11
09
2022
medline:
1
1
2022
pubmed:
1
1
2022
entrez:
31
7
2023
Statut:
ppublish
Résumé
Two emerging diagnostic concepts promote distinct treatments for youth with acute-onset motor abnormalities and severe concurrent psychiatric symptoms: Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric catatonia. Both have institutional approval in parts of Europe and in the USA, meriting an unconditional comparison of supporting evidence. Here we report results of qualitative and quantitative analyses of literature and Swedish National Registry Data suggesting that (1) catatonic patients are liable to fulfilling diagnostic criteria for PANS, (2) three conservatively assessed PANS case-reports present with possible unrecognized catatonia, (3) lithium and electroconvulsive therapy usage frequencies in Swedish minors (exclusively recommended for severe mental illness) are strongly intercorrelated and unequally distributed across Swedish counties, (4) established severe mental disorders are rarely overtly considered amongst PANS-specific research and (5) best-available evidence treatments appear markedly superior for pediatric catatonia compared to PANS in both childhood and adolescence. Prioritizing treatments for pediatric catatonia in concerned subjects could markedly improve treatment outcomes.
Identifiants
pubmed: 37521496
doi: 10.1038/s44184-022-00013-8
pii: 13
pmc: PMC9533273
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no competing interests.
Références
Psychosomatics. 2018 Nov;59(6):531-538
pubmed: 30104020
World J Psychiatry. 2016 Dec 22;6(4):391-398
pubmed: 28078203
Lancet Child Adolesc Health. 2021 Jun;5(6):e19-e21
pubmed: 33961798
Eur Child Adolesc Psychiatry. 2015 Apr;24(4):441-9
pubmed: 25159089
PLoS One. 2011 Mar 17;6(3):e18029
pubmed: 21437291
Nutr Clin Pract. 2019 Feb;34(1):60-72
pubmed: 30570169
Neurosci Biobehav Rev. 2018 Mar;86:51-65
pubmed: 29309797
J ECT. 2010 Dec;26(4):266-9
pubmed: 21155151
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):38-47
pubmed: 25695943
Front Psychiatry. 2014 Dec 09;5:181
pubmed: 25538636
Acta Psychiatr Scand. 1996 Feb;93(2):129-36
pubmed: 8686483
Eur Child Adolesc Psychiatry. 2022 Oct;31(10):1645-1648
pubmed: 34091778
BMJ. 2003 Dec 20;327(7429):1459-61
pubmed: 14684649
J Pediatr. 2012 Apr;160(4):667-672.e2
pubmed: 22050870
Scientometrics. 2017;111(2):1053-1070
pubmed: 28490825
Child Psychiatry Hum Dev. 2022 Apr;53(2):354-364
pubmed: 33559023
J Child Adolesc Psychopharmacol. 2019 Oct;29(8):625-633
pubmed: 31170007
Front Psychiatry. 2021 Mar 24;12:637886
pubmed: 33841207
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):31-7
pubmed: 25695942
Front Immunol. 2018 Jun 08;9:1299
pubmed: 29951056
Acta Paediatr. 2021 Dec;110(12):3153-3160
pubmed: 33848371
J ECT. 2021 Sep 1;37(3):158-170
pubmed: 34424874
Schizophr Res. 2016 Oct;176(2-3):378-386
pubmed: 27377978
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
Neuropsychiatr Dis Treat. 2015 Apr 02;11:941-9
pubmed: 25897230
Lancet Child Adolesc Health. 2019 Mar;3(3):175-180
pubmed: 30704875
Schizophr Res. 2018 Oct;200:56-67
pubmed: 28754582
JAMA Netw Open. 2020 May 1;3(5):e204063
pubmed: 32364596
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):167-176
pubmed: 27093093
CNS Spectr. 2016 Aug;21(4):341-8
pubmed: 27255726
Int J Environ Res Public Health. 2019 Apr 02;16(7):
pubmed: 30986980
J Affect Disord. 2011 Dec;135(1-3):1-9
pubmed: 21420736
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jun 8;108:110178
pubmed: 33197507
Int Rev Neurobiol. 2006;72:267-84
pubmed: 16697303
Curr Pediatr Rev. 2020;16(3):183-193
pubmed: 31642785
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110028
pubmed: 32619473
Pediatr Neurol. 2010 Nov;43(5):307-15
pubmed: 20933172
Acta Psychiatr Scand. 2012 Jan;125(1):33-8
pubmed: 22040029
J Child Adolesc Psychopharmacol. 2020 Nov;30(9):567-571
pubmed: 32700992
J Clin Invest. 2021 Jan 19;131(2):
pubmed: 33270605
PLoS One. 2021 Jul 1;16(7):e0253844
pubmed: 34197525
Front Neurol. 2021 Mar 26;12:621637
pubmed: 33841297
Transl Psychiatry. 2018 Jul 31;8(1):139
pubmed: 30065280